Stonegate Capital Partners Updates Coverage on BlackSky Technology Inc. (NYSE: BKSY) 3Q25
BKSY reported revenue, adj EBITDA, and EPS of $19.6M, ($4.5)M, and ($0.44), respectively. This compares to our/consensus estimates of $29.9M/$28.6M, $3.2M/$1.9M, and ($1.06)/($0.36). Imagery and Software Analytical Services revenue decreased to $15.8M, down 8.6% y/y, primarily due to the expected reduction in NRO EOCL tasking and broader U.S. government budget uncertainties that weighed on near-term […]
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NYSE: NUS) 3Q25
NUS reported revenue, adj NI, and adj EPS of $364.2M, $17.1M, and $0.34, respectively. This compares to our estimates of $374.2M, $14.7M, and $0.30, respectively. These results were at the low end of revenue guidance and the high end of EPS guidance. Rhyz delivered $51.6M of revenue, including $47.6M from Manufacturing and $4.0M from Rhyz […]
Stonegate Capital Partners Updates Coverage on Provident Financial Services Inc (NYSE: PFS) 2025 Q3
Stonegate Industry Spotlight: Metals & Mining
Looking ahead to 2026, the metals & mining sector shows compelling demand fundamentals driven by sustained industrial metals consumption, critical minerals for electrification and decarbonization, and constrained near-term supply. Ongoing global infrastructure investment, energy transition demand for battery and renewable-energy metals, and favorable commodity price dynamics support improved earnings visibility for quality producers and explorers. […]
Stonegate Capital Partners Updates Coverage on Gladstone Commercial Corp. (NasdaqGS: GOOD) 3Q25
In the third quarter of 2025, Gladstone Commercial Corp. maintained its disciplined portfolio management approach. The Company ended the quarter with 151 properties across 27 states, expanding its footprint from the previous quarter. During 3Q25, GOOD executed its capital recycling strategy by selling one non-core property, for $3.0M. Additionally, the Company expanded its portfolio by […]
Stonegate Updates Coverage on Information Services Group Inc. Common Stock (NasdaqGM: III) 3Q25
III Revenue for the third quarter totaled $62.3M, up 8% year-over-year when excluding the divested automation unit, exceeding guidance. Excluding prior-year contributions from the divested automation business, segment revenue in the Americas increased to $42.2M, representing growth of ~11.0% y/y. On the same basis, Europe returned to growth, up 7% y/y, while Asia-Pacific remained softer. […]
Stonegate Industry Spotlight: Banks
Looking forward to 2026, the landscape for community and regional banks continues to look positive. Improved profitability, growing fee income, efficiencies driven by digital transformations, and stable capital positions should be tailwinds. In addition to traditional financials investors, generalists are deploying capital into the sector as they rotate out of other industries. Through proactive investor […]
Stonegate Capital Partners Updates Coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM) 3Q25
In 3Q25, NCSM reported total revenues of $46.5M, a 6.0% year-over-year increase, outperforming broader industry activity levels. Growth reflected higher U.S. and international product sales primarily with fracturing systems (including the North Sea) and wellbore construction in the Middle East. This was partially offset by softer Canadian product sales on lower rig counts. International revenue […]
Stonegate Capital Partners Updates Coverage on OppFi Inc. (NYSE: OPFI) 3Q25
OPFI reported revenue, adj. Net Income, and adj. EPS of $155.1M, $40.7M, and $0.46, respectively. This compares to our/consensus estimates of $155.2M/$153.4M, $27.4M/$28.9M, and $0.30/$0.32. Net revenue margin was 67.4% for the quarter, reflecting a year-over-year expansion of 70 bps from 3Q24. This quarter’s strong performance was driven by yet another record total revenue of […]
Stonegate Capital Partners Updates Coverage on Stepan Company (NYSE: SCL) 3Q25
Stepan’s 3Q25 results reflected continued execution discipline and operational resilience amid persistent oleochemical cost inflation and market normalization across key end markets. Net sales were up 8% y/y, driven by improved pricing and mix and a 1% increase in global sales volumes. Adjusted EBITDA rose 6% y/y while adjusted EPS increased 54% y/y due to […]